Adlina 5

Indications of Adlina 5

Linagliptin is shown within the treatment of sort 2 diabetes mellitus to progress glycaemic control in adults. As monotherapy: in patients insufficiently controlled by count calories and work out alone and for whom metformin is unseemly due to bigotry or contraindicated due to renal impairment. As combination treatment: in combination with metformin when eating less and exercise plus metformin alone don't give satisfactory glycaemic control in combination with a sulphonylurea and metformin when eating less and work out plus dual treatment with these restorative items don't give satisfactory glycaemic control.

 

Pharmaceutical Name

UniMed UniHealth Pharmaceuticals Ltd

 

Pharmacology

Linagliptin is demonstrated to progress glycemic control in patients with sort 2 diabetes mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4), a chemical that corrupts the incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose subordinate insulinotropic polypeptide). Hence, Linagliptin increments the concentrations of dynamic incretin hormones, invigorating the discharge of affront from pancreatic beta (β) cells in a glucose-dependent way and diminishing the emission of glucagon from pancreatic alpha (α) cells within the circulation.

 

Dosage & Administration of Adlina 5

Linagliptin 5 mg once every day. In case included to metformin, the dosage of metformin ought to be kept up and linagliptin managed concomitantly. When utilized in combination with a sulfonylurea, a lower dosage of sulphonylurea may be considered to diminish the chance of hypoglycaemia. Patients with renal disability: No measurements alteration is required. Linagliptin can be taken with or without a supper at any time of the day.

 

Interaction of Adlina 5

Linagliptin could be a powerless competitive and a powerless to direct mechanism-based inhibitor of CYP isozyme CYP3A4 but does not restrain other CYP isozymes. The chance for clinically significant intelligence by other therapeutic items on linagliptin is moo and in clinical ponders linagliptin had no clinically important impact on the pharmacokinetics of metformin, glyburide, simvastatin, warfarin, digoxin or verbal contraceptives.

 

Contraindications

Touchiness to the dynamic substance or to any of the excipients.

 

Side Effects of Adlina 5

When metformin and sulfonylurea are used together, hypoglycemia, nasopharyngitis, cough, and pancreatitis might occur.

 

Pregnancy & Lactation

Category B pregnancy. In pregnant women, there are no sufficient and well-controlled trials. As a result, Linagliptin tablets should only be used during pregnancy if absolutely necessary. It is unknown whether Linagliptin is excreted in breast milk.

 

Precautions & Warnings

Hypersensitivity to the active ingredient or any excipient.

 

Therapeutic Class

Inhibitor of Dipeptidyl Peptidase-4 (DPP-4)

 

Storage Conditions

Keep away from light and heat in a dry location. Keep out of children's reach.

 

Generic Name of Adlina 5

Linagliptin

 

Related Products

• Linajen tablet
• Linax 5 Tablet
• Linita
• Linax 5